Monroe Capital (MRCC)
(Delayed Data from NSDQ)
$7.30 USD
+0.02 (0.27%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $7.29 -0.01 (-0.14%) 5:04 PM ET
4-Sell of 5 4
C Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for Monroe Capital Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 64 | 57 | 54 | 62 | 68 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 64 | 57 | 54 | 62 | 68 |
Selling & Adminstrative & Depr. & Amort Expenses | 18 | 17 | 16 | 13 | 19 |
Income After Depreciation & Amortization | 46 | 39 | 38 | 48 | 49 |
Non-Operating Income | -23 | -25 | 10 | -29 | -10 |
Interest Expense | 23 | 17 | 16 | 18 | 20 |
Pretax Income | 0 | -3 | 32 | 2 | 19 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | -3 | 32 | 2 | 19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 0 | -3 | 32 | 2 | 19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 46 | 39 | 38 | 48 | 49 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 46 | 39 | 38 | 48 | 49 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 21.67 | 21.67 | 21.45 | 20.92 | 20.45 |
Diluted EPS Before Non-Recurring Items | 1.11 | 1.02 | 1.04 | 1.47 | 1.42 |
Diluted Net EPS (GAAP) | 0.02 | -0.13 | 1.51 | 0.08 | 0.94 |
Fiscal Year end for Monroe Capital Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 15.50 | 15.64 | 16.35 | 16.80 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 15.50 | 15.64 | 16.35 | 16.80 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.56 | 4.35 | 4.63 | 4.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 10.94 | 11.29 | 11.72 | 12.14 |
Non-Operating Income | NA | -3.69 | -5.66 | -10.26 | -3.27 |
Interest Expense | NA | 5.67 | 5.87 | 5.79 | 5.51 |
Pretax Income | NA | 1.58 | -0.24 | -4.34 | 3.36 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1.58 | -0.24 | -4.34 | 3.36 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1.58 | -0.24 | -4.34 | 3.36 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 21.67 | 21.67 | 21.67 | 21.67 |
Diluted EPS Before Non-Recurring Items | NA | 0.26 | 0.25 | 0.28 | 0.31 |
Diluted Net EPS (GAAP) | NA | 0.07 | -0.01 | -0.20 | 0.16 |